European private equity firm Cinven is buying a contract research organization in Cincinnati for $915 million. Cinven's Alex Leslie explains why.
FORTUNE -- European private equity firm Cinven today announced that it will acquire Medpace, a Cincinnati-based clinical research organization for biotech and pharma companies, for approximately $915 million from CCMP Capital Advisors. Cinven has been circling this space for a while, having lost out last year on PRA International to MORE
Read more here >> CNNMoney
